» Articles » PMID: 23198743

18F-fluoro-deoxyglucose Positron Emission Tomography/computed Tomography Scan Findings in Rosai-Dorfman Disease with IgG4-positive Plasma Cell Infiltration Mimicking Breast Malignancy: a Case Report and Literature Review

Overview
Journal J Med Case Rep
Publisher Biomed Central
Specialty General Medicine
Date 2012 Dec 4
PMID 23198743
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled:

Introduction: Rosai-Dorfman disease, also known as sinus histiocytosis with massive lymphadenopathy, is a rare benign disorder characterized histologically by lymphatic sinus dilatation due to histiocyte proliferation. Rosai-Dorfman disease accompanied by IgG4+ plasma cell infiltration is an even rarer situation. To the best of our knowledge, no imaging report of fluoro-deoxyglucose positron emission tomography/computed tomography findings of Rosai-Dorfman disease with IgG4+ plasma cell infiltration has been published, although a series of pathological research has focused on this phenomenon.

Case Presentation: We reviewed the 18F-fluoro-deoxyglucose positron emission tomography/computed tomography scan of a 78-year-old Chinese woman with a solid mass that was found in her right breast during a health checkup. 18F-fluoro-deoxyglucose positron emission tomography/computed tomography showed a hypermetabolic nodule in her right breast and slightly heterogeneous increased fluoro-deoxyglucose uptake of the pulmonary nodules, which were histologically proven to be mammary Rosai-Dorfman disease with IgG4+ plasma cell infiltration and pulmonary amyloidosis, respectively. A literature review was performed to gather information on this rare disease process.

Conclusions: Although distinguishing benign lymphoplasmacytic proliferation from malignancy may be difficult with 18F-fluoro-deoxyglucose positron emission tomography/computed tomography in light of the pattern and intensity of fluoro-deoxyglucose uptake, our case highlights that whole-body positron emission tomography/computed tomography imaging not only can display the extent of the disease to help complete staging but also can provide functional information about disease activity to guide biopsy.

Citing Articles

Rosai-Dorfman Disease: Breast Involvement-Case Report and Literature Review.

Iancu G, Gica N, Mustata L, Panaitescu A, Vasile D, Peltecu G Medicina (Kaunas). 2021; 57(11).

PMID: 34833385 PMC: 8624438. DOI: 10.3390/medicina57111167.


Rosai-Dorfman Disease-Utility of 18F-FDG PET/CT for Initial Evaluation and Follow-up.

Mahajan S, Nakajima R, Yabe M, Dogan A, Ulaner G, Yahalom J Clin Nucl Med. 2020; 45(6):e260-e266.

PMID: 32349088 PMC: 8177955. DOI: 10.1097/RLU.0000000000003014.


Multimodality imaging-based evaluation of Rosai-Dorfman disease in the head and neck: A retrospective observational study.

Xu Q, Fu L, Liu C Medicine (Baltimore). 2018; 96(51):e9372.

PMID: 29390533 PMC: 5758235. DOI: 10.1097/MD.0000000000009372.


Rosai-Dorfman Disease of the Breast.

Delaney E, Larkin A, MacMaster S, Sakhdari A, DeBenedectis C Cureus. 2017; 9(4):e1153.

PMID: 28503389 PMC: 5426819. DOI: 10.7759/cureus.1153.

References
1.
Nguyen V, De Petris G, Nguyen B . Usefulness of PET/CT imaging in systemic IgG4-related sclerosing disease. A report of three cases. JOP. 2011; 12(3):297-305. View

2.
Fu Y, Maianu L, Melbert B, Garvey W . Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis. 2004; 32(1):182-90. DOI: 10.1016/j.bcmd.2003.09.002. View

3.
Lim R, Wittram C, Ferry J, Shepard J . FDG PET of Rosai-Dorfman disease of the thymus. AJR Am J Roentgenol. 2004; 182(2):514. DOI: 10.2214/ajr.182.2.1820514. View

4.
Metser U, Even-Sapir E . Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Semin Nucl Med. 2007; 37(3):206-22. DOI: 10.1053/j.semnuclmed.2007.01.001. View

5.
Chan J, Tsang W . Uncommon syndromes of reactive lymphadenopathy. Semin Oncol. 1993; 20(6):648-57. View